Work

A ten-gene tyrosine-metabolism signature defines prognosis and reveals metabo-immune suppression in low-grade astrocytoma

Year: 2026
Type: article
Abstract: BACKGROUND: Emerging evidence implicates dysregulated tyrosine metabolism in glioma malignancy; however, its cell-type specificity and clinical relevance in low-grade astrocytoma (LGA) remain undefined. METHODS: We integrated single-cell transcriptomes from two independent LGA cohorts (GSE182109 and GSE222850) and mapped tyrosine-metabolic activity across the tumor microenvironment using GSVA. Weighted gene co-expression network analysis (WGCNA) of bulk RNA-seq data was performed to identify a tyrosine metabolism-associated gene module, from which hub genes were extracted. A total of 101 machine learning algorithm combinations were systematically evaluated to construct a prognostic signature, which was subsequently validated in the REMBRANDT and CGGA LGA cohorts. Multidimensional functional analyses, immune deconvolution, CellChat-based intercellular communication analysis, and in vitro functional assays were employed to characterize the underlying biological programs and therapeutic implications. RESULTS: At single-cell resolution, tyrosine metabolism activity was preferentially enriched in astrocytes and exhibited dynamic variation along pseudotime trajectories. WGCNA identified a turquoise module (r = 0.61, p = 4 × 10-16), from which 12 hub genes were identified by univariate Cox regression. A Lasso + CoxBoost-based 10-gene tyrosine metabolism risk model was constructed through systematic evaluation of 101 algorithm combinations. High risk scores independently predicted unfavorable 5-year overall survival (AUC = 0.80 in REMBRANDT; AUC = 0.73 in CGGA). High-risk tumors exhibited activation of interferon-γ response, epithelial-mesenchymal transition (EMT), E2F targets, and G2M checkpoint pathways. Immune profiling revealed significantly elevated infiltration of M2 macrophages and activated mast cells in the high-risk group. CellChat analysis demonstrated that high-risk astrocytes engage in intercellular communication via MIF, PTN, and SPP1 signaling pathways. Functional validation in MOG-G-UVW cells confirmed that RAB3C knockdown significantly promoted migration, invasion, and proliferation (p < 0.0001). CONCLUSIONS: We present a single-cell-resolved, clinically validated tyrosine metabolism-based prognostic signature for LGA. This risk model enables quantitative patient stratification, reveals a metabolically reprogrammed and immune-suppressive tumor microenvironment, and identifies RAB3C as a tumor-suppressive modulator, thereby offering new avenues for the precision management of low-grade astrocytoma.
Source: PLoS ONE
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W7234410367
FWCI:
Cites: 31
Cited by:
Related to: 10
Parts: 13